KIROPRAKTISK KLINIK VANLØSE ApS — Credit Rating and Financial Key Figures
CVR number: 35045775
Jernbane Allé 34, 2720 Vanløse
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 2 525.99 | 2 942.64 | 2 615.04 | 3 660.96 | 4 122.31 |
Employee benefit expenses | -2 124.81 | -2 642.27 | -2 459.38 | -3 301.03 | -3 629.36 |
Total depreciation | - 227.29 | - 191.07 | - 215.36 | - 196.31 | - 211.19 |
EBIT | 173.89 | 109.30 | -59.69 | 163.63 | 281.75 |
Other financial income | 0.00 | -4.03 | |||
Other financial expenses | -24.00 | -23.91 | -20.75 | -1.05 | |
Pre-tax profit | 149.89 | 85.39 | -80.44 | 162.58 | 277.72 |
Income taxes | -34.22 | -19.44 | 16.42 | -36.71 | -23.25 |
Net earnings | 115.67 | 65.95 | -64.02 | 125.87 | 254.48 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Buildings | 735.85 | 725.71 | 547.04 | 383.27 | 204.60 |
Machinery and equipment | 58.61 | 121.29 | 84.59 | 80.16 | 47.64 |
Tangible assets total | 794.47 | 847.00 | 631.64 | 463.43 | 252.24 |
Other receivables | 292.63 | 180.13 | 184.61 | 184.61 | 184.61 |
Investments total | 292.63 | 180.13 | 184.61 | 184.61 | 184.61 |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 152.95 | 162.11 | 115.38 | 90.90 | 75.65 |
Prepayments and accrued income | 23.35 | 15.65 | 16.37 | 16.37 | |
Current other receivables | 11.20 | 9.40 | 45.19 | 41.86 | |
Current deferred tax assets | 5.18 | 17.07 | 18.45 | ||
Short term receivables total | 187.51 | 192.34 | 148.82 | 170.91 | 117.51 |
Cash and bank deposits | 522.40 | 464.18 | 166.02 | 355.84 | 349.77 |
Cash and cash equivalents | 522.40 | 464.18 | 166.02 | 355.84 | 349.77 |
Balance sheet total (assets) | 1 797.00 | 1 683.64 | 1 131.09 | 1 174.79 | 904.13 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
Shares repurchased | 120.00 | 65.00 | 65.00 | 60.00 | 200.00 |
Other restricted equity | -65.00 | ||||
Retained earnings | - 105.66 | -54.99 | 10.96 | - 113.05 | - 187.18 |
Profit of the financial year | 115.67 | 65.95 | -64.02 | 125.87 | 254.48 |
Shareholders equity total | 210.01 | 155.96 | 26.95 | 152.82 | 347.30 |
Provisions | 10.92 | 23.54 | 7.01 | 33.10 | |
Non-current loans from credit institutions | 713.11 | 440.17 | |||
Non-current other liabilities | 41.91 | 86.30 | |||
Non-current liabilities total | 755.01 | 526.46 | |||
Current loans from credit institutions | 138.20 | 439.57 | 306.47 | 216.75 | |
Current trade creditors | 576.69 | 282.15 | 256.58 | 298.50 | |
Current owed to group member | 86.98 | ||||
Short-term deferred tax liabilities | 44.99 | 59.20 | |||
Other non-interest bearing current liabilities | 199.37 | 470.34 | 400.98 | 383.91 | 280.88 |
Current liabilities total | 821.06 | 977.67 | 1 097.13 | 988.88 | 556.84 |
Balance sheet total (liabilities) | 1 797.00 | 1 683.64 | 1 131.09 | 1 174.79 | 904.13 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.